Trials / Completed
CompletedNCT04346537
INGEVITY+ Active Fixation Pace/Sense Lead Clinical Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 109 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is it to confirm the safety and effectiveness of the INGEVITY+ Active Fixation Pace/Sense Lead.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | INGEVITY+™ Pace/Sense Lead | The INGEVITY+ lead is indicated for chronic pacing and sensing in the right atrium and/or right ventricle when used with a compatible pulse generator. |
Timeline
- Start date
- 2020-08-06
- Primary completion
- 2021-03-01
- Completion
- 2021-03-01
- First posted
- 2020-04-15
- Last updated
- 2022-07-14
- Results posted
- 2022-05-12
Locations
13 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04346537. Inclusion in this directory is not an endorsement.